DNA in situ Hybridizations for VEGFA Gene Locus (6p12) in Human Tumor Tissue
暂无分享,去创建一个
L. Terracciano | L. Tornillo | L. Quagliata | L. Arabi | M. Andreozzi | S. Schneider | Katharina Burmeister
[1] C. Ruiz,et al. VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities , 2014, Angiogenesis.
[2] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.
[3] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] C. Ruiz,et al. VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal patients , 2011, Modern Pathology.
[5] A. Luini,et al. HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17. , 2007, European journal of cancer.
[6] Inti Zlobec,et al. HER2 gene status in primary breast cancers and matched distant metastases , 2007, Breast Cancer Research.
[7] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[8] C. Sotiriou,et al. Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice , 2005, Clinical Cancer Research.
[9] P. Carroll,et al. Chromosome‐9 loss detected by fluorescence in situ hybridization in bladder cancer , 1995, International journal of cancer.